Autres langues Agile Therapeutics, Inc.

Actions

AGRX

US00847L3087

Marché Fermé - OTC Markets Autres places de cotation 21:50:31 02/05/2024			Varia. 5j.	Varia. 1 janv.
0,4048 ^USD	-7,90%		+9,41%	-79,24%

28/03	Transcript : Agile Therapeutics, Inc., Q4 2023 Earnings Call, Mar 28, 2024
28/03	Agile Therapeutics, Inc. annonce ses résultats pour le quatrième trimestre et l'exercice clos le 31 décembre 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Agile Therapeutics: Q4 Earnings Snapshot	28/03
Earnings Flash (AGRX) AGILE THERAPEUTICS Posts Q4 Revenue $3.6M	28/03
Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate Update	28/03
Agile Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	28/03
Agile Therapeutics, Inc.(OTCPK:AGRX) dropped from S&P TMI Index	28/03
Agile Therapeutics Announces Delisting from Nasdaq	25/03
Agile Therapeutics, Inc.(OTCPK:AGRX) dropped from NASDAQ Composite Index	25/03
North American Morning Briefing : Stocks Struggle After New Records	22/03
Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024	21/03
Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024	20/03
North American Morning Briefing : Stock Futures -2-	19/03
Agile Therapeutics Inc. Completes Pay-Off the Remainder of its Debt Facility	14/03
Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan Execution	13/03
Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross Proceeds	22/02
Top Premarket Gainers	22/02
Agile Therapeutics, Inc. Announces Senior Secured Term Loan Credit Facility of Up to $35.0 Million	15/02
Agile Therapeutics, Inc. Provides Revenue Guidance for the Full Year Ended December 31, 2023	15/02
Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance Update	15/02
AGILE THERAPEUTICS - THE BIDEN-HARRIS ADMINISTRATION ANNOUNCES NEW GUIDANCE TO ENABLE EXPANDED ACCESS TO ALL FDA-APPROVED CONTRACEPTIVES WITHOUT COST	24/01
The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost	23/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Agile Therapeutics, Inc.

Actions

AGRX

US00847L3087

Autres langues

Filtres